CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in VivoAlessandro Antonelli, Paolo Miccoli|The Journal of Clinical Endocrinology & Metabolism|2012Cited by 57